| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT07284459 Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With… |
Trial sites expanded: 60 -> 64 locations |
| 2026-08-04 | NCT07284459 Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With… |
Trial sites expanded: 57 -> 60 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07284459 | Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With… | Idiopathic Pulmonary Fibrosis | Recruiting |